Pages that link to "Q37334961"

The following pages link to Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease. (Q37334961):

Displaying 29 items.

• Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases (Q26859141) (← links)
• Novel Mitochondrial Targets for Neuroprotection (Q27023108) (← links)
• Multi-target drugs: the trend of drug research and development (Q28480888) (← links)
• Acetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos (Q33787815) (← links)
• Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury (Q33965418) (← links)
• Lipoamide Acts as an Indirect Antioxidant by Simultaneously Stimulating Mitochondrial Biogenesis and Phase II Antioxidant Enzyme Systems in ARPE-19 Cells (Q35648531) (← links)
• Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila (Q35860358) (← links)
• Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease (Q36202527) (← links)
• Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. (Q37466088) (← links)
• Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines (Q37580731) (← links)
• The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review (Q37815174) (← links)
• Pharmacological effects and clinical applications of propionyl-L-carnitine. (Q37869187) (← links)
• Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models (Q38009051) (← links)
• Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy (Q38086474) (← links)
• Preconditioning as a potential strategy for the prevention of Parkinson's disease. (Q38201685) (← links)
• Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation injury through AMPK/eNOS/PGC-1α signaling pathway. (Q38924223) (← links)
• Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. (Q39016389) (← links)
• Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma (Q39784228) (← links)
• α-Lipoic Acid Inhibits Expression of IL-8 by Suppressing Activation of MAPK, Jak/Stat, and NF-κB in H. pylori-Infected Gastric Epithelial AGS Cells. (Q40884823) (← links)
• Acetyl‐L‐carnitine‐mediated neuroprotection during hypoxia is attributed to ERK1/2‐Nrf2‐regulated mitochondrial biosynthesis (Q46087901) (← links)
• α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review (Q46252229) (← links)
• Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration. (Q47446148) (← links)
• ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats (Q48152730) (← links)
• Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function (Q48277918) (← links)
• Mitochondrial nutrients stimulate performance and mitochondrial biogenesis in exhaustively exercised rats (Q53252894) (← links)
• The Role of Lipids in Parkinson's Disease (Q61804251) (← links)
• Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention (Q89683589) (← links)
• (r)Alpha Lipoic Acid Is a Safe, Effective Pharmacologic Therapy of Chronic Orthostatic Hypotension Associated with Low Sympathetic Tone (Q90243910) (← links)
• Modified level of miR-376a is associated with Parkinson's disease (Q92598369) (← links)